Why Strive Asset Management (ASST) Is Up +51% in the Last 30 DayStrive, Inc. Class ABATS:ASSTSerhii_BondKey Takeaways ASST stock rose +51% over the past 30 days, driven by Bitcoin treasury expansions, analyst buy ratings, and positive market sentiment toward crypto exposure. Over the past quarter, the stock declined -33%, reflecting high volatility amid Bitcoin price swings and post-acquisition integration challenges. Key factors include Semler Scientific acquisition adding Bitcoin holdings, debt retirement, new capital raises for BTC purchases, and buy ratings from B. Riley and Maxim Group. Recent Q4 earnings highlighted 13,628 BTC holdings despite GAAP losses from unrealized digital asset marks. Volatility tied to Bitcoin correlation, with recovery fueled by institutional interest in Bitcoin treasury strategies. Strive Asset Management (ASST) Company Overview and Market Position Strive Asset Management, LLC (ASST), based in Dallas, Texas, is an investment manager specializing in exchange-traded funds (ETFs) and portfolio management for investment companies. Founded in 2022, the firm conducts in-house research and has pivoted to a Bitcoin treasury strategy, holding over 13,000 BTC as a core asset to maximize long-term shareholder value against fiat depreciation. It offers ETFs focused on value maximization and shareholder engagement, alongside SATA preferred equity for Bitcoin-backed yields. In the competitive asset management industry within financial services, Strive differentiates through its aggressive Bitcoin accumulation, funded by preferred stock offerings and acquisitions like Semler Scientific. This exposure explains recent stock behavior, as ASST acts as a leveraged play on Bitcoin amid crypto market rallies and treasury adoption trends. Strive Asset Management (ASST) Stock Price Performance: Last 30 Days vs. Quarter Over the last 30 days, ASST climbed from a close of $7.16 to $10.85, marking a +51% gain. The movement was volatile but trend-driven, bottoming near $7.02 before surging on crypto momentum and company news, with steady gains accelerating in March. For the past quarter, the stock fell -33% from $16.29 around late December to the current $10.85. It exhibited extreme volatility, peaking above $23 in mid-January post-acquisition before plunging to $7 lows in late February amid broader crypto pullbacks, followed by a partial recovery. What Drove ASST Stock Price in the Last 30 Days The 30-day rally stemmed from heightened investor enthusiasm for Strive's Bitcoin treasury buildup. Key catalysts included March 11 announcements of SATA enhancements and additional Bitcoin/STRC purchases, boosting holdings and signaling disciplined capital allocation. Q4 earnings on March 19 revealed 13,628 BTC ($668.5M fair value) and a 22.2% Bitcoin yield, despite $393.6M GAAP net loss from unrealized losses and impairments. Analyst actions fueled sentiment: B. Riley initiated Buy coverage March 10 with $12 target; Maxim reiterated Buy, trimming target to $20 from $30 on March 23, citing BTC accumulation and balance sheet strength. These aligned with Bitcoin's rebound above $67K, amplifying ASST's high-beta correlation. Trading volume spiked on news days, underscoring retail and institutional interest in the firm's top-10 public BTC holder status. What Drove ASST Stock Performance Over the Last Quarter The quarterly decline reflected Bitcoin's volatility and integration risks from the January Semler Scientific acquisition, adding ~5,000 BTC but triggering share drops amid debt swaps and market corrections. Early surges followed the deal's shareholder approval and $225M capital raises for BTC buys and debt retirement (92% payoff), entering top-10 BTC holders. Macro pressures like Bitcoin retracing from peaks weighed heavily, with ASST's beta amplifying losses to $7 lows. Sustained narratives included shift to "Bitcoin Treasury Asset Management," anti-ESG ETFs managing $2B, but cumulative impacts from unrealized losses and high short interest curbed upside. Institutional flows into crypto treasuries provided partial support late-quarter. Trending AI Robots Tickeron’s Trending AI Robots page showcases the platform's top-performing AI-driven trading bots from hundreds available, scanning thousands of tickers across strategies like trend-following, mean reversion, and momentum plays. These curated bots highlight real-time leaders by metrics such as win rate, profit factor, Sharpe ratio, and timeframe suitability—from scalping to long-term holds. Updated dynamically, the section aids traders in selecting bots aligned with market conditions or personal risk profiles. Explore Tickeron’s AI robots to enhance your trading edge with data-backed automation. ASST Stock Forecast Drivers: What Investors Should Watch Next Investors should monitor upcoming earnings for updates on Bitcoin yield, holdings growth, and asset management inflows. Track Bitcoin price trends and crypto regulation shifts, as ASST's performance correlates strongly. Watch Semler integration progress via Clinivanta operations and further SATA offerings for capital deployment. Analyst revisions, institutional ownership changes, and macroeconomic factors like interest rates impacting risk assets remain key. Potential catalysts include additional acquisitions or ETF launches; risks involve BTC volatility, dilution, and impairment charges. Momentum Indicator for ASST turns positive, indicating new upward trend ASST saw its Momentum Indicator move above the 0 level on February 26, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator turned positive. In 43 of the 47 cases, the stock moved higher in the following days. The odds of a move higher are at 90%. Price Prediction Chart Technical Analysis (Indicators) Bullish Trend Analysis The Moving Average Convergence Divergence (MACD) for ASST just turned positive on February 23, 2026. Looking at past instances where ASST's MACD turned positive, the stock continued to rise in 21 of 22 cases over the following month. The odds of a continued upward trend are 90%. Following a +16.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASST advanced for three days, in 103 of 122 cases, the price rose further within the following month. The odds of a continued upward trend are 84%. The Aroon Indicator entered an Uptrend today. In 41 of 51 cases where ASST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%. Bearish Trend Analysis The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 14 of 16 cases where ASST's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%. Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%. ASST broke above its upper Bollinger Band on March 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. Fundamental Analysis (Ratings) The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. ASST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents. The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.170) is normal, around the industry mean (3.985). P/E Ratio (0.000) is within average values for comparable stocks, (26.457). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.256). Dividend Yield (0.000) settles around the average of (0.086) among similar stocks. P/S Ratio (63.291) is also within normal values, averaging (44.700). The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents. The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock. The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.